August 2005
Bidding War for Unocal

China National Offshore Oil Corp. (CNOOC) and Chevron Corp. participated in a bidding war for possession of Unocal. CNOOC initially offered $18.5 billion (Euro 15.2 billion), but raised its all cash offer to $19 billion (Euro 15.7 billion). Chevron's bid was valued at $16.5 billion and included both cash and stock. Concerns about economic and national security were raised by the U.S. Congress with respect to the CNOOC bid. The company had agreed to a review by the Committee on Foreign Investment in the U.S. [CFIUS]. Shareholders of CNOOC were also expected to be unfavorable towards the bid. In the end, Unocal accepted a revised $17 billion (Euro 14 billion) offer from Chevron.

 

Famous Quotes of the Month

- It is a fine thing to have ability, but the ability to discover ability in others is the true test. (Elbert Hubbard)

- Difficulties mastered are opportunities won. (Winston Churchill)

- In the business world, everyone is paid in two coins: cash and experience. Take the experience
first; the cash will come later. (Harold S. Geneen)

- Discovery consists of looking at the same thing as everyone else and thinking something different. (Albert Szent-Gyorgyi)

- Never express yourself more clearly than you are able to think. (Niels Bohr)




Why Do Some Restaurants and Clubs Put Ice in the Urinals?
While we were not able to come up with a defnitive answer to this question, we did generate a lot of theories. In America, as opposed to Europe, many urinals require a manual flush. Since very few men will actually bother to do this, the melting ice acts as a slow, continuous flush. Moreover, the ice cools the air in and around the urinal. Since cool air sinks, the ice serves to contain the smell. The melting ice also dilutes the urine reducing the concentration and thereby controlling the odor. The traditional method for containing the smell is to use toilet cakes. But ice is a lot cheapter to use than toilet cakes as most restaurants have ice making machines linked to a water tap. Toilet cakes also have to be replaced on a regular basis while ice just has to be dumped into the urinal. It is an input only system. Since many toilet cakes use camphor oil, they have an odor of their own which becomes stronger as patrons forget to flush. Some people find the smell somewhat offensive. And ice does a better job than toilet cakes of masking the smell of other liquids like beer and vomit. Another theory is that ice makes bathroom cleanliness more enforceable. If the manager sees that the ice has melted, they know that the bathroom attendant has not been there to clean. Conversely, if the patrons see that the urinals are full of ice, the implication is that the bathroom is getting periodic attention and that they are being cleaned. And let's not forget the entertainment value of the ice. Men can't write their names in the ice but they do report playing other games trying to melt the ice in different ways.




New Managing Director for Total Petrochemicals
Andrew Ritchie, currently vice president of Total Petrochemicals China, has been appointed to replace the retiring David Gresham as managing director of Total Petrochemicals UK. Ritchie will take the position at the end of 2005. He has worked for Total Petrochemicals since 1980 when he joined Ato Chemical Products, which ultimately became Total.




Chemical Exports on the Rise in Russia
In the first five months of 2005, Russia had $4.52 billion (Euro 3.77 billion) of chemical exports, an increase of 23.7 percent compared to the same period in 2004. According to the federal customs service, chemicals accounted for 5.8 percent of Russia's total exports. Key chemical products included potash ($406.5 million), Nitrogen fertilizers ($556 million), synthetic rubber ($419 million), and Ammonia ($207 million).



China's Currency Revaluation May Impact Chemical Industry
The People's Bank of China revalued the Chinese Renminbi to 8.11 to the U.S. dollar, up over 2 percent from 8.28. Other Asian currencies are expected to appreciate in response to the revaluation. A slight decline in the international competitiveness of some Asian exports is expected. On the flip side, the cost of raw material imports will decline for Chinese chemical companies. Further rises in the value of the Chinese currency are also likely. Many predict appreciation to take place over the next several years. According to the American Chemistry Council, a 10 percent rise in the value of the Chinese yuan could result in an increase of American chemical exports to China of as much as $350 million (Euro 246 million) by 2006-2007.



Export Duty on Petrochemicals to Rise Again in Russia
Beginning August 1, 2005, Russia's export duty on petrochemicals will increase by 2.4 percent. Chemicals affected include Benzene, Butadiene, Butene, Ethylene, Propylene, Toluene, and Xylene, among others. The duty will apply to all countries that have not signed customs union agreements with Russia. Since January 1, the export duty has climbed from $57/tonne to $106.6/tonne.



Intellectual Property Still a Factor When Conducting Business in China
Although China has signed the World Trade Organization (WTO) agreement on Trade-Related Aspects of Intellectual Property Rights (Trips), many say the country is not enforcing the standards. The country has amended laws covering trademarks, patents, and copyright issues, and introduced the provision of injunction orders to comply with the agreement. Problems arise because local governments play a significant role in the legal system, and enforcement and regulations vary widely from province to province. Discrimination against foreign companies is also an ongoing problem.



Positive Results for Many IPOs in the Chemical Industry
Four companies formed through IPOs in 2004 (Huntsman, Celanese, Nalco, and Westlake) are mostly trading above their IPO prices, and analysts expect they will continue to perform well. Huntsman initially saw its stock price rise well above its IPO price, then fall well below, then return to close to its original price. Many analysts believe the company will do well because of its diversification. Celanese has been able to capitalize on lower Ethylene and natural gas costs and a favorable acetyls market. Nalco has seen its trading price rise 19 percent over its IPO price. The company has been able to push through price increases and reduce costs in underperforming business segments. Westlake Chemical Company has experienced large gains due to the economic situation in the Chloralkali and Ethylene markets. Future IPOs include Hexion Specialty Chemicals and Rockwood Holdings.




Chemtura Launched

Shareholders finalized the merger of Crompton Corporation and Great Lakes Chemical to form Chemtura, a new company with revenues of $3.7 billion (Euro 3.09 billion) that began trading on the New York Stock Exchange (CEM) as of July 5, 2005. According to the company, Chemtura has leading positions in plastics additives, petroleum additives, flame retardants, and pool chemicals. Savings of as much as $150 million are expected to be achieved through synergies, according to president and CEO Robert Wood. Approximately 600 positions will be eliminated globally over the next year.

Chemtura will focus on organometallic specialties as a growth opportunity, and has formed a new business unit under the name OMS encompassing this activity. The business, formerly part of Crompton's operations, manufactures organotin and metal alkyls used in a wide variety of applications. Nearly half of OMS' sales are attributed to catalysts used for olefin polymerization. The company plans to grow its other market segments, particularly pharmaceuticals and fine chemicals. Increasing its position in Asia is also a goal.



European Specialty Chemicals Sector Sees Growth
Rising prices and increasing demand for specialty chemicals in Europe had participants at the recent ChemSpec Europe feeling positive about the sector. Several companies indicated that double-digit sales growth was anticipated for 2005. Those supplying pharmaceutical intermediates said that the number of projects being outsourced by pharma companies is also growing. However, companies are concerned about the influx of products manufactured in non-European Union (EU) countries that are made in plants not inspected by EU authorities. This problem should be addressed to some extent by new regulations that are due to take effect in November.



Goodyear to Exit Adhesives Market with Sale to Sartomer

Sartomer Company Inc. will pay about $65 million to acquire the Wingtack adhesives resins business of Goodyear Tire & Rubber Company. Sartomer, along with Cray Valley and Cook Composites & Polymers, are units of Total SA and make up the second-largest resins producer worldwide. The Wingtack purchase will expand its line of products for adhesives and sealants. The sale will enable Goodyear to focus its chemical group on development of synthetic rubber for its tire business.




Jubilant Agrees to Acquire Trinity Laboratories
Jubilant Organosys agreed to purchase a 65 percent stake in U.S. generic drug firm Trinity Laboratories, including subsidiary Trigen Laboratories, for $12.5 million. Jubilant expects to increase its holding in the company to 75 percent by the end of 2006 through an additional $8.4 million investment. Trigen manufactures dosage forms of generic drugs. Bulk manufacturing will continue in India, and drug finishing will take place at Trigen.



Solvay Reaches Agreement on Details of Fournier Pharma Acquisition
Solvay announced that it has agreed to purchase Fournier Pharma for approximately $1.9 billion (Euro 1.6 billion). The company will pay an initial $1.43 billion (Euro 1.2 billion), with additional payments of up to $470 million (Euro 400 million) based on future developments and milestones. Solvay received approval from the European Commission (EC) for the transaction. The deal is expected to be completed in the third quarter of 2005.



Teva to Acquire Ivax for $7.4 Billion

Teva Pharmaceuticals announced that it will acquire Ivax Corporation for $7.4 billion (Euro 6.1 billion). Combined sales of the two companies will total approximately $6.64 billion, making the merged entity the largest generic drug manufacturer in the world. The deal is expected to close in late 2005 or early 2006, once regulatory and shareholder approvals are obtained.




Worldwide Pesticides Market Stable
Global consumption of pesticides in 2004 totaled 5 million tonne valued at $33 billion (Euro 27.6 billion), up slightly from $31.8 billion in 2001, according to the Hochburg consulting firm. Leading pesticide categories include herbicides ($15 billion), insecticides ($9 billion), and fungicides ($6 billion). Nematicides, fumigants, and rodenticides accounted for the remaining $3 billion. The U.S. market was valued at $11.2 billion, or 35 percent of total global production. The leading six manufacturers accounted for 83 percent of worldwide pesticide output. The largest application for pesticides is in agriculture.




Monsanto Continues to Have Difficulties in Argentina
Monsanto filed a lawsuit in Denmark seeking to prevent Argentina from exporting soybeans to the European Union because it has not yet received royalty payments from growers that used the company's Roundup Ready seeds. The Argentine government is unlikely to approve Monsanto's application for its genetically modified Bacillus thuringiensis (Bt) 10 corn seed because of this action. Agriculture officials in the country are opposed to the charging of royalty fees on crops. Monsanto says the royalties are necessary because many farmers obtain the seed illegally or use second-generation seeds without permission.



Short Capacity Anticipated for Biologics Manufacture
Not too long ago, biologics capacity was in short supply. Today there is an excess. But manufacturers are predicting that the growth of the biopharma market will once again lead to a capacity crunch in some sectors. According to consulting company HighTech Business Decisions, the contract biologic pharma market is valued at $1.7 billion, and is led by Boehringer Ingelheim, Akzo Nobel's Diosynth unit, and DSM. Some peg the growth rate at 16 percent or more per year. Large pharmaceutical companies tend to outsource the manufacture of more mature biologic drugs to free up capacity for new products. Smaller biopharma firms often outsource all of their production needs.




Caustic Soda Inventories Very Low in Europe
The European Chlor-alkali producers association Euro Chlor reported that inventories of Caustic soda in the European Union (EU), Norway, and Switzerland have declined to their lowest recorded level. June inventories are down nearly 15 percent as compared to June levels in 2004. Chlorine production fell slightly during the first half of 2005, according to the group.



Demand for Methanol Drops in India
Methanol producers in India are cutting back on production in response to weakened demand and reduced margins. Deepak Fertilizers and Petrochemicals Corp. is producing more Ammonia to make Ammonium nitrate and has reduced its operating capacity for Methanol from 70-80 percent in June to 50 percent at the end of July. Prices of Methanol are down by 6-10 percent from early June levels. Monsoon season often causes a reduction in the Methanol market in July and August.



Global Acetone Prices Declining
Decreased demand combined with high inventory levels has resulted in a steady decline in global spot prices for Acetone. In some cases, prices have dropped as much as 15 percent since early June. These lower prices are now below feedstock costs.



Positive Outlook for U.S. Citric Acid Market
Stabilizing prices and expected positive demand growth are combining to make the outlook for U.S. Citric acid very attractive. Both spot and contract prices have steadied over the past six months after an extended period of decline. The increasing demand for beverages during the summer combined with the shift of Chinese producers from the North American market to Europe has improved conditions. It is possible that a shortage of supply could occur if Canadian oil producers begin using Citric acid to increase oil recovery, a potential new application for this chemical. The high oil prices are making it economically attractive to pursue the recovery process. One Canadian company has committed to using the process, and four or five others are investigating its potential. Demand for this application could reach as much as 50,000 metric tons annually.




Phthalates Banned from use in Toys in Europe
The use of phthalates in toys and childcare articles has been permanently banned by the European Parliament through a recent vote which is expected to be formally approved later this year. A temporary ban has been in place since 1999. The European Council for Plasticizers and Intermediates (ECPI)